NCT01395199View on ClinicalTrials.gov

Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
ThalassemiaIron Overload
Interventions
DRUG

Amlodipine

5mg PO initially; may be reduced to 2.5mg PO if side effects

Trial Locations (1)

13100000

Universidade Estadual de Campinas, Campinas

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Campinas, Brazil

OTHER

NCT01395199 - Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major | Biotech Hunter | Biotech Hunter